Physician profile
Alexander Bennett
NPI 1285208546
$5,278.35
in general payments reported to CMS, 2019-2025
14 companies · $1,224 in 2025
The $1,224 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.86 · 2022: $2,383 · 2023: $595 · 2024: $1,031 · 2025: $1,224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,849.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,351.05 | 2022-2024 | |
| Glaukos Corporation | $558.52 | 2023-2025 | Kxl System (Not Refurbished), Kxl1b-Ce-Marked Kxlsystem |
| Visioneering Technologies, INC. | $534.84 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $508.14 | 2022-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $489.81 | 2024-2025 | Xdemvy |
| Coopervision INC. | $210.14 | 2023-2025 | Myday Contact Lens, Misight Contact Lens |
| Alcon Vision LLC | $181.09 | 2022-2025 | Total30, Precision 1, Eysuvis |
| Bausch & Lomb Americas INC. | $142.72 | 2023-2025 | Xiidra, Miebo, Infuse |
| Harrow Eye, LLC | $108.06 | 2024-2025 | Vevye |
| Dompe US, INC. | $56.99 | 2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $54.38 | 2021-2023 | |
| Oyster Point Pharma, INC. | $45.76 | 2022-2023 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.84 | 2021 | |
| Lkc Technologies, INC. | $13.01 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.